Insmed Incorporated
INSM
Kedudukan dalam Saham
#1102
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Harga Saham
$96.65
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$21.11B
Perubahan (1 hari)
-2.59%
Perubahan (1 tahun)
-41.70%
Negara
US
Perdagangan Insmed Incorporated (INSM)
Kategori
Healthcare
Margin Operasi untuk Insmed Incorporated (INSM)
Margin Operasi pada October 2026 TTM: -71.86%
Menurut laporan kewangan dan harga saham terkini Insmed Incorporated, margin operasi semasa (TTM) ialah -71.86%. Pada akhir 2023, margin operasi syarikat ialah -232.51%.
Sejarah Margin Operasi untuk Insmed Incorporated dari 2000 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Ubah |
|---|---|---|
| 2026 (TTM) | -71.86% | -70.24% |
| 2024 | -241.47% | 3.85% |
| 2023 | -232.51% | 19.32% |
| 2022 | -194.87% | -0.14% |
| 2021 | -195.14% | 20.96% |
| 2020 | -161.32% | -6.42% |
| 2019 | -172.38% | -94.48% |
| 2018 | -3,124.94% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | -100.00% |
| 2014 | -759.70% | 58.80% |
| 2013 | -478.39% | 0.00% |
| 2012 | 0.00% | -100.00% |
| 2011 | -1,397.31% | 1,095.10% |
| 2010 | -116.92% | 39.82% |
| 2009 | -83.62% | -32.12% |
| 2008 | -123.18% | -54.62% |
| 2007 | -271.47% | -95.05% |
| 2006 | -5,486.68% | -73.80% |
| 2005 | -20,941.98% | 4.61% |
| 2004 | -20,018.25% | 183.65% |
| 2003 | -7,057.33% | 272.65% |
| 2002 | -1,893.81% | -86.05% |
| 2001 | -13,576.35% | -90.01% |
| 2000 | -135,891.67% | 0.00% |
Margin Operasi untuk syarikat serupa atau pesaing
| Syarikat | Margin Operasi | Perbezaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | -100.54% |
US
|
|
| -149.01% | -97.93% |
US
|
|
| 25.57% | -100.36% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -100.40% |
NL
|
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.